Hospital Sirio Libanes

Caba, Ciudad Autonoma Buenos Aires C1419GEP

1 studies enrolling now · 2 studies all time

What they study most

Dyslipidemia, Recurrent or Metastatic Solid Tumors, Type2 Diabetes

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) — Recruiting now
• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early